Gastric Neuroendocrine Tumor Treatment and Survival Outcome Depends on Facility Type

Rebecca M Platoff1, Johanna Lou1, Kathryn Bush2

  • 1Department of Surgery, Cooper University Hospital, Camden, NJ, USA.

The American Surgeon
|June 20, 2022
PubMed
Abstract

Insights

Patients with gastric neuroendocrine tumors (gNETs) treated at academic centers showed improved survival. Academic programs offered better outcomes for gNET treatment, especially with surgery or chemotherapy.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Health Services Research

Background:

  • Gastric neuroendocrine tumors (gNETs) are rare malignancies.
  • Surgical intervention may enhance survival for gNET patients.
  • The impact of treatment facility type on gNET outcomes is not well-established.

Purpose of the Study:

  • To investigate the association between healthcare facility type and treatment patterns for gastric neuroendocrine tumors.
  • To evaluate the effect of facility type on overall survival in patients with gNETs.

Main Methods:

  • Utilized the National Cancer Database (NCDB) to identify patients diagnosed with gNET between 2004 and 2016.
  • Stratified patients based on facility type: Academic/Research Program (ARP), Community Cancer Program (CCP), Comprehensive Community Cancer Program (CCCP), and Integrated Network Cancer Program (INCP).
  • Compared overall survival and clinical/demographic characteristics, employing propensity score matching for robust analysis.

Main Results:

  • Patients treated at academic programs experienced significantly longer median survival (137.3 months) compared to other facility types (88.0-100.2 months; P < .0001).
  • Academic centers demonstrated higher rates of surgical intervention (64.2%) compared to CCP, CCCP, and INCP (51.4%-59.1%; P < .0001).
  • Survival benefits associated with academic centers persisted after propensity matching, particularly for patients receiving surgery (P < .0001) and chemotherapy (P = .04).

Conclusions:

  • Treatment at an academic hospital is associated with improved median survival for patients with gastric neuroendocrine tumors.
  • Academic medical centers may offer superior outcomes for gNET management compared to community-based centers.
  • The findings suggest a potential benefit for patients seeking gNET treatment at specialized academic facilities.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
444
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
274
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
403